In the present study, we underscored a heterogeneous expression of PHGDH among CRC patients and we confirmed high PHGDH levels in organoids and tumor tissue specimens from patients less responsive to 5-FU-based therapy. The gene discussed is PHGDH; the disease is colorectal carcinoma.